To assess the utility of US health insurance data for surveillance of hereditary hemorrhagic telangiectasia, an autosomal-dominant blood vasculature disorder with an estimated prevalence of 1.5–2.0 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback